Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05282901
Title Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) (PLUME)
Acronym PLUME
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Curie RECRUITING Paris 75005 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field